Annals of Internal Medicine tip sheet, December 5, 2000

December 04, 2000

December 5, 2000, Tip Sheet

Annals of Internal Medicine is published by the American College of Physicians-American Society of Internal Medicine (ACP-ASIM), an organization of more than 115,000 internal medicine physicians and medical students. The following highlights are not intended to substitute for articles as sources of information. For an embargoed fax of an article, call 1-800-523-1546, ext. 2656 or 215-351-2656. Full content of the issue is available on the Internet at http://www.annals.org on December 5, 2000.

* * *

Procedure effective in treating heart rhythm problem

Radiofrequency ablation, a cardiac procedure, improves the quality of life for patients with frequent supraventricular tachycardia attacks, a cost-effectiveness study finds (Article, p. 864). Radiofrequency ablation destroys a small section of heart tissue that causes the irregular heartbeat, or supraventricular tachycardia. The procedure reduces the number of attacks requiring emergency hospital or physician visits per year and, though expensive, is cost-effective in comparison to managing the condition with long-term drug therapy or treating the episodes as they occur.

* * *

Alternative Cancer Therapy Apparently Caused Death of One Patient

A cancer patient who refused traditional treatment and took hydrazine sulfate, a chemical compound he obtained through the Internet, died from liver and kidney failure, according to a case report (Brief Communication, p. 877). The authors surmise that the hydrazine sulfate, a chemical used in jet fuel, caused the death. Some studies have shown that hydrazine sulfate prevents severe weight loss suffered by some cancer patients. The compound is advertised on the Internet as having "virtually no significant untoward side effects." The authors stress the importance of reporting adverse events of both prescription and non-prescription therapies. An editorial says that, while existing studies show "little evidence to support its ability to shrink tumors or cure cancer," hydrazine sulfate has had relatively few reported serious side effects prior to this case report (Editorial, p. 911). Still, the editorial says, "there seems to be little justification for the drug's easy availability and unsupervised use."

* * *

Protein Erythropoietin Reduces Need for Transfusion After Hip Surgery (Article, p. 845).
-end-


American College of Physicians

Related Cancer Patients Articles from Brightsurf:

Higher risk of death in cancer patients with COVID-19 may be due to advanced age and more pre-existing conditions, rather than cancer itself
New research presented at this this week's ESCMID Conference on Coronavirus Diseases (ECCVID, online 23-25 September) suggests that the poor outcomes and higher death rates in cancer patients with COVID-19 could be due to them generally being older and having more underlying conditions, rather than due to the cancer itself.

The Lancet: Prostate cancer study finds molecular imaging could transform management of patients with aggressive cancer
Results from a randomised controlled trial involving 300 prostate cancer patients find that a molecular imaging technique is more accurate than conventional medical imaging and recommends the scans be introduced into routine clinical practice.

The art of cancer caregiving: How art therapies benefits those caring for cancer patients
A recent Drexel University study showed coloring and open-studio art therapy benefits stressed caregivers of cancer patients.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer tissue-freezing approach may help more breast cancer patients in lower income countries
A new reusable device created by the Johns Hopkins University can help women with breast cancer in lower income countries by using carbon dioxide, a widely available and affordable gas, to power a cancer tissue-freezing probe instead of industry-standard argon.

Lots of patients with cancer, cancer survivors use but don't report complementary/alternative medicine therapies
This study used data from a nationwide survey to estimate how many patients with cancer and cancer survivors use complementary and alternative medicines (CAMS) in addition to or instead of conventional therapies, and how many don't disclose that to their physicians.

Colorectal cancer in patients with early onset is distinct from that in older patients
New research indicates that colorectal cancer diagnosed at an early age has clinical and genetic features that are different from those seen in traditional colorectal cancer diagnosed later in life.

Comparable risk of recurrent venous thromboembolism between patients with unprovoked venous thromboembolism and patients with cancer
Patients with venous thromboembolism (VTE) carry a high risk of recurrence.

Personalized cancer vaccine may increase long-term survival in patients with deadly brain cancer
An international Phase III study led by researchers at UCLA has found that a personalized GBM vaccine may increase long-term survival in some patients.

Ovarian cancer drug shows promise in pancreatic cancer patients with BRCA mutation
A targeted therapy that has shown its power in fighting ovarian cancer in women including those with BRCA1 and BRCA2 mutations may also help patients with aggressive pancreatic cancer who harbor these mutations and have few or no other treatment options.

Read More: Cancer Patients News and Cancer Patients Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.